<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30061223</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>08</Month>            <Day>06</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>06</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1791-7530</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>38</Volume>                    <Issue>8</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                    </PubDate>                </JournalIssue>                <Title>Anticancer research</Title>                <ISOAbbreviation>Anticancer Res.</ISOAbbreviation>            </Journal>            <ArticleTitle>Evaluation of the Antitumor Potential of the Resorcinolic Lipid 3-Heptyl-3,4,6-trimethoxy-3H-isobenzofuran-1-one in Breast Cancer Cells.</ArticleTitle>            <Pagination>                <MedlinePgn>4565-4576</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.21873/anticanres.12761</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND/AIM" NlmCategory="OBJECTIVE">In recent years, the search for new anticancer experimental agents derived from natural products or synthetic analogues, such as resorcinolic lipids, has received increased attention. The present study aimed to evaluate the antitumor potential, describe the cell death mechanism and the effects of 3-Heptyl-3,4,6-trimethoxy-3Hisobenzofuran-1-one (AMS35AA) in combination with different chemotherapeutic agents in the MCF-7 cell line.</AbstractText>                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Analysis of cytotoxic, genotoxic, membrane integrity, cell death and gene expression induced by the compound was performed.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The AMS35AA and its association with 5-FU demonstrated reduction of cell viability; increase of cell death; enhancement of genomic damage and accumulation of cells in G<sub>2</sub>/M phase.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">AMS35AA has potential for breast cancer treatment since it is capable of exerting cytotoxic and cytostatic effects in a breast cell line and also could be an adjuvant in cancer therapy when combined with 5-FU.</AbstractText>                <CopyrightInformation>Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Rabacow</LastName>                    <ForeName>Ana Paula Maluf</ForeName>                    <Initials>APM</Initials>                    <AffiliationInfo>                        <Affiliation>Stem Cell Study Center, Cell Therapy and Toxicological Genetics - CeTroGen, Maria Aparecida Pedrossian University Hospital - HUMAP, Brazilian Hospital Services Company - EBSERH, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Post-graduate Program in Health and Development in the Central-West Region, Dr. Hélio Mandetta Medical School - FAMED, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Meza</LastName>                    <ForeName>Alisson</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Post-graduate Program in Chemistry, Institute of Chemistry, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>DE Oliveira</LastName>                    <ForeName>Edwin José Torres</ForeName>                    <Initials>EJT</Initials>                    <AffiliationInfo>                        <Affiliation>Stem Cell Study Center, Cell Therapy and Toxicological Genetics - CeTroGen, Maria Aparecida Pedrossian University Hospital - HUMAP, Brazilian Hospital Services Company - EBSERH, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Post-graduate Program in Genetics and Molecular Biology, Center for Biological Sciences, State University of Londrina, Londrina/PR, Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>DE David</LastName>                    <ForeName>Natan</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Stem Cell Study Center, Cell Therapy and Toxicological Genetics - CeTroGen, Maria Aparecida Pedrossian University Hospital - HUMAP, Brazilian Hospital Services Company - EBSERH, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vitor</LastName>                    <ForeName>Neimar</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Post-graduate Program in Chemistry, Institute of Chemistry, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Antoniolli-Silva</LastName>                    <ForeName>Andréia Conceição Milan Brochado</ForeName>                    <Initials>ACMB</Initials>                    <AffiliationInfo>                        <Affiliation>Stem Cell Study Center, Cell Therapy and Toxicological Genetics - CeTroGen, Maria Aparecida Pedrossian University Hospital - HUMAP, Brazilian Hospital Services Company - EBSERH, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Post-graduate Program in Health and Development in the Central-West Region, Dr. Hélio Mandetta Medical School - FAMED, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>DE Fátima Cepa Matos</LastName>                    <ForeName>Maria</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Laboratory of Molecular Biology and Cell Cultures, Federal University of Mato Grosso do Sul, UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Perdomo</LastName>                    <ForeName>Renata Trentim</ForeName>                    <Initials>RT</Initials>                    <AffiliationInfo>                        <Affiliation>Laboratory of Molecular Biology and Cell Cultures, Federal University of Mato Grosso do Sul, UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>DA Silva Gomes</LastName>                    <ForeName>Roberto</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Faculty of Exact Sciences and Technology - FACET, Federal University of Grande Dourados - UFGD, Dourados, MS, Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>DE Lima</LastName>                    <ForeName>Dênis Pires</ForeName>                    <Initials>DP</Initials>                    <AffiliationInfo>                        <Affiliation>Post-graduate Program in Chemistry, Institute of Chemistry, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Master Program in Pharmacy, Center for Biological and Health Sciences - CCBS, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Beatriz</LastName>                    <ForeName>Adilson</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Post-graduate Program in Chemistry, Institute of Chemistry, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Master Program in Pharmacy, Center for Biological and Health Sciences - CCBS, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Oliveira</LastName>                    <ForeName>Rodrigo Juliano</ForeName>                    <Initials>RJ</Initials>                    <AffiliationInfo>                        <Affiliation>Stem Cell Study Center, Cell Therapy and Toxicological Genetics - CeTroGen, Maria Aparecida Pedrossian University Hospital - HUMAP, Brazilian Hospital Services Company - EBSERH, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil rodrigo.oliveira@ufms.br.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Post-graduate Program in Health and Development in the Central-West Region, Dr. Hélio Mandetta Medical School - FAMED, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Master Program in Pharmacy, Center for Biological and Health Sciences - CCBS, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Greece</Country>            <MedlineTA>Anticancer Res</MedlineTA>            <NlmUniqueID>8102988</NlmUniqueID>            <ISSNLinking>0250-7005</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D008055">Lipids</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D059565" MajorTopicYN="N">G2 Phase Cell Cycle Checkpoints</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName>                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D061986" MajorTopicYN="N">MCF-7 Cells</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">5-FU</Keyword>            <Keyword MajorTopicYN="N">Resorcinolic lipids</Keyword>            <Keyword MajorTopicYN="N">breast cancer</Keyword>            <Keyword MajorTopicYN="N">cytotoxicity</Keyword>            <Keyword MajorTopicYN="N">genotoxicity</Keyword>            <Keyword MajorTopicYN="N">qPCR</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>17</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>06</Month>                <Day>02</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>04</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30061223</ArticleId>            <ArticleId IdType="pii">38/8/4565</ArticleId>            <ArticleId IdType="doi">10.21873/anticanres.12761</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>